SFRP5 weakens Wnt signaling by binding to Wnt5a, thereby inhibiting the development of cardiovascular diseases such as atherosclerosis [14], coronary heart disease [15, 16], myocardial infarction [17, 18], and myocardial hypertrophy [19]. Here, SFRP5 is linked to atherosclerosis.